Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of software for pharmaceutical discovery and development, today announced that it has been named “Company of the Month” in the May issue of the investment newsletter The Bowser Report. Now in its 34th year, The Bowser Report is one of the oldest investment newsletters specializing in the analysis of low-priced, small-cap stocks.
Walt Woltosz, chairman and chief executive officer of Simulations Plus, commented: “We’re pleased and honored to have been selected as “Company of the Month” by The Bowser Report. Through the first two quarters of our 2010 fiscal year, we have achieved record highs in our revenues and earnings, shareholder equity has continued to grow, our cash flow is strong, and we continue to have no debt. We believe these gains are the culmination of years of hard work coupled with the broader adoption of simulation technologies by the pharmaceutical industry, and we’re genuinely grateful to Max Bowser for acknowledging our efforts to the global community of subscribers who follow his investment advice.”